Search Icon
ALZN Archived Articles

Alzamend Neuro (ALZN): Pioneering Novel Therapeutics for Alzheimer's, Bipolar Disorder, and More

Published on March 15, 2025

Alzamend Neuro (NASDAQ:ALZN): A Clinical-Stage Biopharmaceutical Company Driving Innovative Alzheimer’s and Mental Health Treatments

Published on November 30, 2024

Alzamend Neuro, Inc. (NASDAQ:ALZN): Promising Alzheimer's and Neuropsychiatric Therapeutics Pipeline, But Liquidity Concerns Remain

Published on September 24, 2024